Merck & Co. Inc. (MRK) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 1, 2026.

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free
Filings shown
10
Open-market buys
0
Open-market sells
17

Counts cover the 10 most recent Form 4 filings Tradune holds for MRK (filed Aug 7 – Oct 1, 2026). No completed check of MRK's Form 4 list on SEC EDGAR is on record yet; the latest MRK filing Tradune holds was filed Oct 1, 2026. This is not guaranteed to be the complete record — see MRK's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 10 filings Tradune holds for MRK filed Aug 7 – Oct 1, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

17 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
0 sales· 0 sh
checkbox disclosed
On filings with the box not checked
0 sales· 0 sh
not proof that no plan exists
Not comparable
17 sales· 228,238 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Richard R. DeLucaEVP&Pres, Merck Animal Heallth 0 8 — 51,370 −$6,731,142
David Michael WilliamsEVP,Chief Info&Digital Officer 0 3 — 52,847 −$6,805,145
David R. MaraldoEVP & Pres. MMD 0 3 — 18,706 −$2,407,797
Chirfi GuindoEVP, Access, Policy & Comms 0 2 — 25,000 −$3,315,000
Jennifer ZacharyEVP, General Counsel 0 1 — 80,315 −$10,718,495

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score
0/ 100
Net insider sales
0 distinct buyers0 buy · 17 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at MRK

No open-market insider purchases (Form 4 code P) were reported for MRK in the trailing 90 days. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Christine E. Seidman Director · filed Oct 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Phantom Stock 56 $145.31 — — Sep 30, 2026
Surendralal Lanca Karsanbhai Director · filed Oct 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Phantom Stock 112 $145.31 — — Sep 30, 2026
Mary Ellen Coe Director · filed Oct 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Phantom Stock 206 $145.31 — — Sep 30, 2026
Chirfi Guindo EVP, Access, Policy & Comms · filed Aug 13, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10,000 $135.00 — — Aug 13, 2026
Jennifer Zachary EVP, General Counsel · filed Aug 13, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 41,494 $117.89 — — Aug 12, 2026
Option exercise Stock Option (Right to Buy) 13,433 — — — Aug 12, 2026
Option exercise Stock Option (Right to Buy) 41,494 — — — Aug 12, 2026
Open-market sale 80,315 $133.46 — — Aug 12, 2026
Option exercise 13,433 $84.71 — — Aug 12, 2026
Richard R. DeLuca EVP&Pres, Merck Animal Heallth · filed Aug 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 600 $132.04 — — Aug 12, 2026
Open-market sale 11,099 $131.61 — — Aug 12, 2026
Open-market sale 5,427 $132.35 — — Aug 11, 2026
Open-market sale 7,410 $131.33 — — Aug 11, 2026
Open-market sale 20,784 $130.43 — — Aug 10, 2026
Richard R. DeLuca EVP&Pres, Merck Animal Heallth · filed Aug 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 300 $131.02 — — Aug 6, 2026
Open-market sale 805 $131.02 — — Aug 6, 2026
Open-market sale 4,945 $130.23 — — Aug 6, 2026
Chirfi Guindo EVP, Access, Policy & Comms · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 15,000 $131.00 — — Aug 6, 2026
David R. Maraldo EVP & Pres. MMD · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 2,686 $128.72 — — Aug 5, 2026
Option exercise 2,686 $84.71 — — Aug 5, 2026
Open-market sale 9,709 $128.72 — — Aug 5, 2026
Option exercise 9,709 $87.10 — — Aug 5, 2026
Open-market sale 6,311 $128.72 — — Aug 5, 2026
Option exercise 6,311 $73.73 — — Aug 5, 2026
David Michael Williams EVP,Chief Info&Digital Officer · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 34,705 $128.77 — — Aug 5, 2026
Option exercise 34,705 $73.73 — — Aug 5, 2026
Open-market sale 13,542 $128.77 — — Aug 5, 2026
Option exercise 13,542 $75.36 — — Aug 5, 2026
Open-market sale 4,600 $128.77 — — Aug 5, 2026
Option exercise 4,600 $77.62 — — Aug 5, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to MRK's (Oct 1, 2026).

Frequently asked about MRK insider activity

How many insiders bought MRK stock in the last 90 days?

No open-market purchases (Form 4 code P) of MRK shares were reported by Merck & Co. Inc. insiders in the trailing 90 days. The 10 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for MRK?

The most recent Form 4 on this page was filed by Mary Ellen Coe (Director) on Oct 1, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market MRK insider sale shown?

The largest open-market sale among the filings shown was 80,315 MRK shares at $133.46 (about $10,718,495) by Jennifer Zachary (EVP, General Counsel) on Aug 12, 2026. Value is shares × the price reported on the Form 4; trades may be made under a prearranged Rule 10b5-1 plan.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for MRK — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

Track MRK insider filings free →

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.